These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 32501032

  • 21. Insight into the current practice of ototoxicity monitoring during cisplatin therapy.
    Santucci NM, Garber B, Ivory R, Kuhn MA, Stephen M, Aizenberg D.
    J Otolaryngol Head Neck Surg; 2021 Mar 25; 50(1):19. PubMed ID: 33766142
    [Abstract] [Full Text] [Related]

  • 22. Current practice of ototoxicity management across the United Kingdom (UK).
    Maru D, Malky GA.
    Int J Audiol; 2018 Sep 25; 57(sup4):S76-S88. PubMed ID: 29676584
    [Abstract] [Full Text] [Related]

  • 23. Cisplatin-Induced Ototoxicity: A Concise Review of the Burden, Prevention, and Interception Strategies.
    Chattaraj A, Syed MP, Low CA, Owonikoko TK.
    JCO Oncol Pract; 2023 May 25; 19(5):278-283. PubMed ID: 36921239
    [Abstract] [Full Text] [Related]

  • 24. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy.
    Brown ECM, Caimino C, Benton CL, Baguley DM.
    J Laryngol Otol; 2021 Jan 25; 135(1):14-20. PubMed ID: 33487183
    [Abstract] [Full Text] [Related]

  • 25. [Research progress on the relationship between cisplatin ototoxicity and autophagy].
    Liang Z, Cheng G, Zhang T, Jia H.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb 25; 34(2):189-192. PubMed ID: 32086932
    [Abstract] [Full Text] [Related]

  • 26. A Store-and-Forward Tele-Audiology Solution to Promote Efficient Screenings for Ototoxicity during Cisplatin Cancer Treatment.
    Dille MF, McMillan GP, Helt WJ, Konrad-Martin D, Jacobs P.
    J Am Acad Audiol; 2015 Oct 25; 26(9):750-60. PubMed ID: 26415968
    [Abstract] [Full Text] [Related]

  • 27. Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.
    Konrad-Martin D, Poling GL, Garinis AC, Ortiz CE, Hopper J, O'Connell Bennett K, Dille MF.
    Int J Audiol; 2018 Sep 25; 57(sup4):S3-S18. PubMed ID: 29157038
    [Abstract] [Full Text] [Related]

  • 28. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
    Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L.
    Br J Cancer; 1998 Apr 25; 77(8):1355-62. PubMed ID: 9579846
    [Abstract] [Full Text] [Related]

  • 29. Ototoxicity in cancer survivors: Experience and proposal of a surveillance protocol.
    Sánchez-Canteli M, Núñez-Batalla F, Martínez-González P, de Lucio-Delgado A, Antonio Villegas-Rubio J, Gómez-Martínez JR, Luis Llorente-Pendás J.
    An Pediatr (Engl Ed); 2021 Nov 25; 95(5):290-297. PubMed ID: 34702687
    [Abstract] [Full Text] [Related]

  • 30. Ototoxicity: A review of South African studies.
    Moodley S, Storbeck C, Gama N.
    S Afr Fam Pract (2004); 2021 Mar 15; 63(1):e1-e10. PubMed ID: 33764142
    [Abstract] [Full Text] [Related]

  • 31. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR, Ruggiero A, Lucidi D, De Corso E, Sergi B, Conti G, Paludetti G.
    Audiol Neurootol; 2016 Mar 15; 21(4):203-211. PubMed ID: 27286730
    [Abstract] [Full Text] [Related]

  • 32. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
    Freyer DR, Brock PR, Chang KW, Dupuis LL, Epelman S, Knight K, Mills D, Phillips R, Potter E, Risby D, Simpkin P, Sullivan M, Cabral S, Robinson PD, Sung L.
    Lancet Child Adolesc Health; 2020 Feb 15; 4(2):141-150. PubMed ID: 31866182
    [Abstract] [Full Text] [Related]

  • 33. Pediatric Ototoxicity: Current Trends and Management.
    Fligor BJ.
    Semin Hear; 2019 May 15; 40(2):154-161. PubMed ID: 31036992
    [Abstract] [Full Text] [Related]

  • 34. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
    Pearson SE, Taylor J, Patel P, Baguley DM.
    Int J Audiol; 2019 Nov 15; 58(11):685-695. PubMed ID: 31545660
    [Abstract] [Full Text] [Related]

  • 35. Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.
    Orgel E, Freyer DR, Ullrich NJ, Hardy KK, Thomas SM, Dvorak CC, Esbenshade AJ.
    Pediatr Blood Cancer; 2020 Nov 15; 67(11):e28647. PubMed ID: 32886425
    [Abstract] [Full Text] [Related]

  • 36. Knowledge of final year medicine, pharmacy, audiology and nursing students in South Africa on drug-induced ototoxicity: A pilot study.
    Mogole O, Schellack N, Hollander C, Ramma L.
    S Afr J Commun Disord; 2019 Nov 14; 66(1):e1-e12. PubMed ID: 31793316
    [Abstract] [Full Text] [Related]

  • 37. The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up.
    Skalleberg J, Småstuen MC, Oldenburg J, Osnes T, Fosså SD, Bunne M.
    Laryngoscope; 2020 Sep 14; 130(9):E515-E521. PubMed ID: 32065408
    [Abstract] [Full Text] [Related]

  • 38. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ.
    Pediatr Blood Cancer; 2014 Nov 14; 61(11):2012-7. PubMed ID: 24976616
    [Abstract] [Full Text] [Related]

  • 39. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal H, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O, PanCareLIFE consortium.
    Eur J Cancer; 2020 Oct 14; 138():212-224. PubMed ID: 32905960
    [Abstract] [Full Text] [Related]

  • 40. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
    Clemens E, de Vries AC, Pluijm SF, Am Zehnhoff-Dinnesen A, Tissing WJ, Loonen JJ, van Dulmen-den Broeder E, Bresters D, Versluys B, Kremer LC, van der Pal HJ, van Grotel M, van den Heuvel-Eibrink MM, DCOG-LATER, The Netherlands.
    Eur J Cancer; 2016 Dec 14; 69():77-85. PubMed ID: 27821322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.